Requests that the FDA reclassify azelaic acid, at concentrations up to and including 15%, from prescription-only status to over-the-counter availability in the United States.
🏛 Food and Drug Administration (FDA)FDA-2026-P-8162
Documents
2
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jul 24, 2026No comment period